Is there an optimal thrombolytic regimen?
D Collen - Coronary Artery Disease, 1994 - journals.lww.com
The causative role of coronarv artery thrombosis in acute transmural myocardial infarction is
well estab-lished [1, 2]. Rupture of atheromatous plaque leads to occlusive thrombosis …
well estab-lished [1, 2]. Rupture of atheromatous plaque leads to occlusive thrombosis …
t-PA in thrombolytic therapy of acute myocardial infarct
W Rutsch, H Schmutzler - Herz, 1994 - pubmed.ncbi.nlm.nih.gov
In the past decade, thrombolytic therapy has become standard treatment of acute myocardial
infarction. When the importance of thrombosis in the pathogenesis of acute infarction was …
infarction. When the importance of thrombosis in the pathogenesis of acute infarction was …
Thrombolysis for acute myocardial infarction: making sense of the clinical trials data
JL ANDERSON - Journal of Interventional Cardiology, 1992 - Wiley Online Library
Trials during the 1980s established that thrombolytic therapy restores coronary blood flow
rapidly and reduces mortality compared to control or placebo therapy in acute myocardial …
rapidly and reduces mortality compared to control or placebo therapy in acute myocardial …
Lessons we have learned from the GUSTO trial
DR Holmes Jr, RM Califf, EJ Topol - Journal of the American College of …, 1995 - Elsevier
Thrombolytic therapy remains a mainstay for the treatment of patients with acute myocardial
infarction. This therapy has been the subject of intense investigation and multiple studies as …
infarction. This therapy has been the subject of intense investigation and multiple studies as …
What data support our current thrombolytic management of patients with acute myocardial infarction?
JC Sobolski - Progress in cardiovascular diseases, 1992 - Elsevier
The DECADE of the eighties is character-ized by major advances in the management of
patients with evolving myocardial infarction. Large-scale, placebo-controlled studies have …
patients with evolving myocardial infarction. Large-scale, placebo-controlled studies have …
Systemic thrombolytic therapy of acute myocardial infarction?
D Collen, M Verstraete - Circulation, 1983 - Am Heart Assoc
The rationale for thrombolytic treatment of acute myocardial infarction is based on two
established facts and a reasonable assumption. The first fact is that a thrombus obstructing …
established facts and a reasonable assumption. The first fact is that a thrombus obstructing …
Thrombolytic therapy.
D Collen, DC Stump, HK Gold - Annual review of medicine, 1988 - europepmc.org
Thrombolytic agents are plasminogen activators that convert plasminogen, the inactive
proenzyme of the fibrinolytic system in blood, to the proteolytic enzyme plasmin. Plasmin in …
proenzyme of the fibrinolytic system in blood, to the proteolytic enzyme plasmin. Plasmin in …
The GUSTO-I Trial
C Granger - The Modern Era of Coronary Thrombolysis, 1994 - Springer
In the past 10 years, thrombolytics have become standard therapy for patients presenting in
the early hours of acute myocard ial infarction with ST segment elevation. The …
the early hours of acute myocard ial infarction with ST segment elevation. The …
Future directions in thrombolysis for myocardial infarction: what are the unanswered questions?
J Lefkovits, EJ Topol - Coronary Artery Disease, 1994 - journals.lww.com
Substantial advances have been made in the application of intravenous thrombolytic agents
for acute myocardial infarction since their introduction 10 years ago. Dosage regimens and …
for acute myocardial infarction since their introduction 10 years ago. Dosage regimens and …
Thrombolytic therapy: A review of its use in acute myocardial infarction
ED Bizjak, VF Mauro - Annals of Pharmacotherapy, 1998 - journals.sagepub.com
OBJECTIVE: To review the literature on the use of thrombolytic agents in the
pharmacotherapeutic management of acute myocardial infarction (AMI). DATA SOURCE …
pharmacotherapeutic management of acute myocardial infarction (AMI). DATA SOURCE …